Acentric Research is produced with AI tools under human review. The authors are not financial professionals, and nothing here is investment advice or a recommendation to buy or sell any security. AI analysis can be wrong; check every claim against its cited source.
This Brief is an initial scan, not a full investigation. The method and scores behind it are in Biotechnology × Space in the Landscape Report.
Overview
TRISH, an institute at Baylor College of Medicine, says deep-space exploration presents mental, physical and emotional challenges such as neurocognitive changes and radiation exposure. [1] NASA's Human Research Program says it funds studies to protect astronaut health and performance on such missions, covering muscle and bone health, sex differences, crew autonomy and behaviour, balance and disorientation, and inflammation of the brain or spinal cord. [2] This Junction covers the medical technology and research behind that.
In the 2023 NASA round, the work is early and small-scale. NASA's 2023 round funded eight studies, about $1.2 million in total, each lasting up to a year; six of the eight are at universities or research institutes. [2] The dated sources opened are from 2023 to 2025, plus a programme page that lists projects from 2017 to 2025 and an undated company page with newsroom items to October 2026; later developments were not searched.
Current state
What the technology does. The studies in NASA's 2023 round were chosen from 60 proposals by dual anonymous peer review and checked for relevance to NASA's Human Research Roadmap. They are done on Earth, without samples or data from astronauts. NASA says the Program pursues methods and technologies for safe human space travel through laboratory science, ground analogues and the ISS. [2] Examples named in the release are bone changes in mice during simulated unloading and spaceflight, skeletal muscle atrophy under simulated microgravity, effects of proton radiation on bone, targeting aged cells to reduce radiation-induced inflammation in the brain, and a radioisotope source for X-ray imaging in flight. [2] Two of the eight are led by companies: Teamscape LLC, on negotiating crew autonomy, and Ultra Safe Nuclear Corporation – Space, on the radioisotope source. [2]
Who is working on it. The Translational Research Institute for Space Health (TRISH), based at Baylor College of Medicine, describes itself as leading a national effort to turn biomedical research into ways to reduce health risks in deep space. It says it funds both early-stage research and more mature technologies, and its programmes include EXPAND, Hermes and SENTINEL. It says it began in 2017 and gives funding, access and strategic guidance to outside teams; EXPAND works with commercial spaceflight providers and their participants on human research. [1]
Its project list includes work by companies, for example Ejenta on conversational agents for astronaut behavioural health (2020–2021) and Z3VR on cognitive testing in virtual environments, as well as a company project on probiotics against mental-health risks of space travel (Holobiome, 2020–2021), a NASA Ames study on defining an on-demand "astropharmacy" and a University of California, Davis study of space-based production of a therapeutic in plants (both 2024–2025). [1] Voyager Technologies says it develops technologies for the medical and physiological problems of spaceflight, including small, low-power, non-invasive instruments (company description). [3] KBR, a contractor, reported a NASA contract with a $2.5 billion ceiling value for a base period, to support astronaut health, occupational health and research (a ceiling, not money spent). [4]
How far it has come. Mostly funded research, in the sources opened. The 2023 studies are one-year projects. These sources describe funded research; they do not list products in use, and none was searched for. [2][1]
Opportunities
NASA says the studies may let it better mitigate risks and protect astronaut health and performance on missions to the ISS, the Moon, Mars and beyond. [2] TRISH says it funds both early-stage, high-risk research and more mature, translation-ready technologies, and that its work aims to help people thrive in space and on Earth, and that the work could create a paradigm shift in healthcare during space exploration. [1]
Challenges
- Physics and engineering. Neurocognitive change and radiation exposure are the problems TRISH names, along with other stressors; muscle and bone loss appear among the funded project titles. The sources opened give no solved case. [1] Voyager describes its instruments as small, low-power and non-invasive, tailored to mission requirements. [3]
- Evidence. The 2023 studies are ground studies and simulations, and the release gives no results; whether their findings carry over to crews in flight is not addressed in the sources opened. [2]
- Capital and scale-up. The 2023 round totals about $1.2 million across eight one-year projects. [2] The contract value in the KBR release is a ceiling, not a count of money spent, and does not say how much of it goes to any one technology. [4]
Data sources
- NASA Task Book and Human Research Program pages, for funded studies. [5][2]
- TRISH programme pages, for its awards (amounts are not stated on the page opened). [1]
- SEC EDGAR, for contract announcements by contractors. [6]
- NIH RePORTER, for federal grants. [7]
- No registry of astronaut-health technology outcomes was found, and no source opened describes how a space-health device or treatment would be reviewed.
Changelog
- 2026-11-18: First published.
Sources
- Translational Research Institute for Space Health (TRISH), Baylor College of Medicine, "TRISH Research" (programme page, undated; lists projects dated 2017 to 2025; amounts are not stated on the page). bcm.edu(accessed 2026-11-18)
- NASA, "NASA Funds Eight Studies to Protect Astronaut Health on Long Missions", Human Research Program, 2023-09-29 (agency release). nasa.gov (accessed 2026-11-18)
- Voyager Technologies, "Space Solutions" (company page, undated, with newsroom items to October 2026; a company description). voyagertechnologies.com (accessed 2026-11-18)
- KBR, Inc., Form 8-K exhibit 99.1, filed 2025-10-30 (company release; the contract value is a ceiling, not money spent). sec.gov (accessed 2026-11-18)
- NASA Task Book, research project records. taskbook.nasaprs.com (named on the TRISH page as the record of its projects; listed as a data source, not opened for this Brief)
- SEC EDGAR, full-text search. sec.gov (listed as a data source; not run for this Brief)
- NIH RePORTER, project search. reporter.nih.gov (listed as a data source; not opened for this Brief)